Skip to main content
. 2021 Jun 10;35(11):6358–6365. doi: 10.1007/s00464-021-08567-y

Fig. 3.

Fig. 3

Target tissue temperature profile in two hIBUB organs (blue and red lines) during hPIPAC. The therapeutic phase begins at the end of the chemotherapy administration (spraying) phase. The infrared energy source restores and maintains the temperature of the target tissue within the desired therapeutic hyperthermia range (highlighted blue area) for the time needed (30 min) (Color figure online)